Daniel G Walsh MD
Adult Congenital Heart Disease, Interventional Cardiology
Assistant Professor, Internal Medicine, Oakland University Wm Beaumont SOM
Join to View Full Profile
27901 Woodward AveSte 300Berkley, MI 48072
Phone+1 248-545-0070
Fax+1 248-545-4850
Dr. Walsh is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
University of MichiganFellowship, Cardiovascular Disease, 1988 - 1992- University of MichiganResidency, Internal Medicine, 1981 - 1984
Weill Cornell MedicineClass of 1981
Certifications & Licensure
MI State Medical License 1984 - 2027
IN State Medical License 2016 - 2019
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Cardiovascular Disease
Awards, Honors, & Recognition
- Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2012
Publications & Presentations
PubMed
- 1 citationsImpact of Defibrillator Electrode Placement on Outcome of Electrical Cardioversion of Atrial Fibrillation: A Pilot Observational Study.Luai Madanat, Josh France, Nolan Shoukri, Abhay N Bilolikar, Daniel Walsh
Journal of the American Heart Association. 2024-07-02 - Isolated Cardiac Sarcoidosis Presenting as High-Degree Atrioventricular Block.Ryian Owusu, Hazem Alakhras, Kateryna Strubchevska, Daniel G Walsh
Cureus. 2024-06-01 - 9 citationsReperfusion arrhythmia: myth or reality?Richard E. Burney, Daniel G Walsh, Lenore R Kaplan, Shawn Fraser, Benjamin Tung
Annals of Emergency Medicine. 1989-03-01
Press Mentions
Thyroid Dermopathy and Thyroid Eye Disease Associated with Hypofunctional Autoimmune Thyroid Disease with High TSI/anti-TSHR Antibodies Improved with TeprotumumabDecember 22nd, 2024- Talimogene Laherparepvec (T-VEC) and Emerging Intralesional Immunotherapies for Metastatic Melanoma: A ReviewDecember 19th, 2024
- Hemophagocytic Lymphohistiocytosis in a Critically Ill Patient: A Case Report of a Potentially Fatal EntityDecember 1st, 2024
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
